| Entire cohort |
---|---|
 | (n = 4,836) |
Demographics | Â |
   Age, years | 64.4 ± 14.2 |
   Female sex, n (%) | 1,633 (34) |
Medical history | Â |
   Diabetes, n (%) | 981 (20) |
   Hypertension, n (%) | 3,246 (67) |
   Chronic lung disease, n (%) | 293 (13) |
   Extracardiac arteriopathy, n (%) | 985 (20) |
   History of renal failure, n (%) | 172 (4) |
Baseline renal function | Â |
   Baseline serum creatinine, mg/dL | 1.13 ± 0.29 |
   Patients with baseline serum creatinine >2.0 mg/dL, n (%) | 63 (1) |
   Baseline eGFR, mL/min/1.73 m2 | 68 ± 19 |
   Baseline eGFR >60 mL/min/1.73 m2, n (%) | 3,181 (66) |
   Baseline eGFR 31 to 60 mL/min/1.73 m2, n (%) | 1,596 (33) |
   Baseline eGFR ≤30 mL/min/1.73 m2, n (%) | 50 (1) |
Preoperative cardiac status | Â |
   Prior cardiac surgery, n (%) | 721 (15) |
   LVEF >60%, n (%) | 2,405 (50) |
   LVEF 41-60%, n (%) | 1,655 (34) |
   LVEF 21-40, n (%) | 442 (9) |
   LVEF ≤20%, n (%) | 55 (1) |
   LVEF (missing value), n (%) | 279 (6) |
   History of Myocardial infarction, n (%) | 1,027 (21) |
   Congestive heart failure, n (%) | 775 (16) |
   NYHA functional class IV, n (%) | 913 (19) |
   Cardiogenic shock, n (%) | 34 (1) |
   Preoperative IABP, n (%) | 77 (2) |
   Preop on inotropes, n (%) | 114 (2) |
Operative details | Â |
   CABG only, n (%) | 1,258 (26) |
   CABG & Valve only, n (%) | 566 (12) |
   Valve surgery, n (%) | 1,196 (25) |
   Other/Combined surgery, n (%) | 1,816 (37) |
   Elective surgery, (%) | 3,947 (82) |
   Urgent surgery, n (%) | 811 (17) |
   Emergent surgery & rescue, n (%) | 78 (2) |
   CPB duration, minutes | 85 ± 48 |
   Cross-clamp time, minutes | 58 ± 32 |
   Patients with circulatory arrest, n (%) | 220 (5) |
Outcomes | Â |
   Intra/postop IABP, n (%) | 173 (4) |
   Intra/Postop ECMO or VAD, n (%) | 20 (0.4) |
   Revision for bleeding, n (%) | 192 (4) |
   Operative mortality, n (%) | 89 (1.8) |
   Hospital length of stay (alive), days | 6 (5 to 8) |